MARSHALLS PLC LS -,25/ GB00B012BV22 /
2024-05-02 7:32:05 PM | Chg. +0.040 | Volume | Bid7:32:09 PM | Ask7:32:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3.140EUR | +1.29% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 644.99 mill.EUR | - | - |
GlobeNewswire
11:01 PM
Martinrea International Inc. Reports Strong First Quarter Results and Declares Dividend
GlobeNewswire
11:00 PM
Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Developmen...
GlobeNewswire
11:00 PM
Post Holdings Reports Results for the Second Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Ou...
GlobeNewswire
11:00 PM
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufa...
GlobeNewswire
10:56 PM
Park Hotels & Resorts Inc. Announces Upsizing and Pricing of Senior Notes Offering
GlobeNewswire
10:37 PM
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:30 PM
UMH PROPERTIES, INC. REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2024
GlobeNewswire
10:30 PM
Host Hotels & Resorts Provides Updated First Quarter 2024 Investor Presentation
GlobeNewswire
10:30 PM
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Un...
GlobeNewswire
10:30 PM
Japan Smaller Capitalization Fund, Inc. Announces Change to Deputy Portfolio Manager
GlobeNewswire
10:30 PM
Okeanis Eco Tankers Corp. – Announcement of 2024 Annual Meeting of Shareholders
GlobeNewswire
10:25 PM
Greenlight Capital Re, Ltd. Schedules First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
10:23 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. -...